Fatta Nahab, MD

Fatta Nahab serves as the Vice President of Clinical and Digital Development at Neuron23. He is a board-certified Neurologist and Movement Disorders specialist with over 20 years of experience bridging clinical development needs with technological advancements in digital health technologies.

Dr. Nahab spent the first 15 years of his career in academia, caring for patients, leading novel clinical trials, and doing research using advanced imaging techniques and digital health technologies. Prior to joining Neuron23, Dr. Nahab served as the Head of Movement Disorders Science at Biogen Digital Health. At Neuron23, Dr. Nahab leads the LRRK2-inhibitor Phase-2 clinical development program of a disease-modifying therapy (NEU-411) for Parkinson’s disease. Dr Nahab received his MD and his residency training in Neurology from Loma Linda University, and a Movement Disorder/MRI fellowship from the NIH.